Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Wells Fargo's top pharma picks for 2024
05:33pm, Friday, 15'th Dec 2023
Mohit Bansal, Wells Fargo Analyst, joins 'Closing Bell: Overtime' to discuss Wells Fargo's pharma picks for 2024.
The New Magnificent 7: 7 Stocks Rising to Prominence
08:55am, Friday, 15'th Dec 2023
The magnificent seven stocks have had a fantastic 2023. Those firms dominate Silicon Valley and are amongst seven of the largest eight firms globally, as measured by market capitalization.
Where Will Eli Lilly Be in 5 Years?
06:15am, Friday, 15'th Dec 2023
Eli Lilly's recently approved weight-loss treatment Zepbound has the potential to be a game changer. The company has other weight-loss products in the works that could help it dominate the anti-obesit
What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch
11:29am, Wednesday, 13'th Dec 2023
Health care stocks to check out in the stock market now.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 13'th Dec 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history
10:08am, Wednesday, 13'th Dec 2023
Ken Langone, Invemed Associates chairman and Home Depot co-founder, joins 'Squawk Box' to discuss the state of the pharmaceutical industry, including Pfizer's weaker than expected 2024 forecast, the g
Strategist: Buy Baxter stock, skip Eli Lilly stock
04:18pm, Tuesday, 12'th Dec 2023
Novo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype.
LLY Down as Patients Regain Weight After Stopping Zepbound
03:02pm, Tuesday, 12'th Dec 2023
Full results from a late-stage study show that patients who stopped taking Eli Lilly's (LLY) weight-loss drug for over a year slowly started to regain their lost weight.
Eli Lilly Stock Slips After Reported Weight Gain In Users Who Quit Its Drug
04:45pm, Monday, 11'th Dec 2023
Eli Lilly (LLY) shares fell 2.3% Monday after a study conducted by the drug maker found patients who use its weight-loss treatments may gain weight once they stop taking the drugs.
Patients regain weight after stopping Eli Lilly's Zepbound, study says
01:53pm, Monday, 11'th Dec 2023
The data suggests that people have to stay on the weekly injection Zepbound if they want to maintain weight loss.
Eli Lilly Stock Falls on Data That Show Patients Who Stopped Zepbound Regained Weight
01:07pm, Monday, 11'th Dec 2023
A JAMA study shows that patients who stopped taking Zepbound after 36 weeks on the drug experienced a 14% weight regain over a year.
Midday Movers: Cigna Soars After Calling Off Humana Deal, Eli Lilly Falls Following Study
12:55pm, Monday, 11'th Dec 2023
U.S. equities were little changed at midday ahead of key inflation data due later in the week and the final Federal Reserve policy meeting of 2023. The Dow and S&P 500 were up slightly, while the Nasd
Here's what will happen if you stopped taking Eli Lilly's weight-loss drug
12:54pm, Monday, 11'th Dec 2023
Eli Lilly & Co (NYSE: LLY) is down nearly 4.0% today after a study indicated that weight-loss from Zepbound tends to reverse once the treatment is stopped. Patients regain weight if they stop taking Z
Eli Lilly obesity drug patients regained weight after ending treatment: study
12:21pm, Monday, 11'th Dec 2023
Individuals using Eli Lilly and Co (NYSE:LLY)'s obesity drug Zepbound (tirzepatide) regained weight after they stopped using the treatment, according to a study published Monday in the Journal of the
Patients on Eli Lilly's drug regain weight after stopping treatment - JAMA study
10:55am, Monday, 11'th Dec 2023
Patients on Eli Lilly's weight-loss drug trial substantially regained weight after stopping treatment, according to a study published in journal JAMA on Monday.
